Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical TrialAnne Montfort, Nicolás Meyer|Clinical Cancer Research|2020Cited by 101